THURSDAY, April 6, 2023 (HealthDay News) An RSV vaccine developed by Pfizer provides safe and effective protection in both seniors and newborns, clinical trial results show.
Late-stage RSV vaccine trials show 'exciting promise,' some scientists say localnews8.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from localnews8.com Daily Mail and Mail on Sunday newspapers.
A Pfizer vaccine to protect older adults and infants from respiratory syncytial virus (RSV) infection has shown what some scientists are calling "exciting" promise in late-stage trials.